Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | 0.092 | 0.008 |
mRNA | masitinib | CTRPv2 | pan-cancer | AAC | -0.096 | 0.008 |
mRNA | BRD-K09587429 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.009 |
mRNA | BRD-K14844214 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.009 |
mRNA | AUY922 | GDSC1000 | pan-cancer | AAC | 0.091 | 0.009 |
mRNA | methylstat | CTRPv2 | pan-cancer | AAC | -0.11 | 0.009 |
mRNA | LAQ824 | GDSC1000 | pan-cancer | AAC | 0.088 | 0.009 |
mRNA | carboplatin:UNC0638 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.098 | 0.009 |
mRNA | Panobinostat | FIMM | pan-cancer | AAC | -0.29 | 0.009 |
mRNA | JNJ-26854165 | CTRPv2 | pan-cancer | AAC | -0.089 | 0.009 |